Pancreatic cancer in adults : diagnosis and management /

The evidence reviewed for this guideline has highlighted the lack of useful national data on 19 pancreatic cancer in the UK. In many cancers, national datasets have contributed 20 significantly to improving outcomes of patient management. For pancreatic cancer, there has 21 been no comprehensive nat...

Full description

Saved in:
Bibliographic Details
Online Access: Full text
Corporate Authors: National Guideline Alliance (Great Britain) (Author), Royal College of Obstetricians and Gynaecologists (Great Britain) (sponsoring body.)
Format: Electronic eBook
Language:English
Published: London : National Institute for Health and Care Excellence, 2018
Edition:Final.
Series:National clinical practice guideline ; NG85.
Subjects:

MARC

LEADER 00000cam a2200000 i 4500
001 p2596291
005 20240206154740.0
006 m o d
007 cr cn ||||||||
008 190314s2018 enka ob 000 0 eng
020 |z 9781473127944 
035 |a (DNLM)BKSHLF:NBK487233 
035 |a 1748489 
040 |a DNLM  |b eng  |e rda  |c DNLM  |d UtOrBLW 
042 |a pcc 
043 |a e-uk--- 
060 0 0 |a WI 810 
110 2 |a National Guideline Alliance (Great Britain),  |e author.  |0 n 2016190861 
245 1 0 |a Pancreatic cancer in adults :  |b diagnosis and management /  |c developed by the National Guideline Alliance ; hosted by the Royal College of Obstetricians and Gynaecologists. 
250 |a Final. 
264 1 |a London :  |b National Institute for Health and Care Excellence,  |c February 2018. 
300 |a 1 online resource (1 PDF file (699 pages)) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a NICE guideline ;  |v NG85 
504 |a Includes bibliographical references. 
520 3 |a The evidence reviewed for this guideline has highlighted the lack of useful national data on 19 pancreatic cancer in the UK. In many cancers, national datasets have contributed 20 significantly to improving outcomes of patient management. For pancreatic cancer, there has 21 been no comprehensive national database and therefore comparing outcomes between 22 pancreatic centres and pancreatic specialists has not been possible. This lack of continuous 23 audit may result in inappropriate variation in the standard of treatments between centres. The 24 Committee is of the unanimous opinion that a national database of pancreatic cancer 25 patients needs to be established to provide a continuous comparative audit of patient 26 management. 
530 |a Issued also in print. 
588 |a Description based on online resource; title from PDF title page (viewed August 28, 2019). 
650 1 2 |a Pancreatic Neoplasms  |x diagnosis.  |0 D010190Q000175 
650 1 2 |a Pancreatic Neoplasms  |x therapy.  |0 D010190Q000628 
651 2 |a United Kingdom.  |0 D006113 
655 2 |a Practice Guideline.  |0 D017065 
710 2 |a National Institute for Health and Care Excellence (Great Britain),  |e issuing body.  |0 n 2013188573 
710 2 |a Royal College of Obstetricians and Gynaecologists (Great Britain),  |e sponsoring body.  |0 n 79145318  
830 0 |a National clinical practice guideline ;  |v NG85.  |0 no2010197276 
951 |a 2596291 
998 |a BKSHLF  |b 20190314 
999 f f |i 855cfde5-5fa4-5ecb-a166-c5211986c69e  |s 120db848-a3a7-5368-a2bd-6fc2b04f6de9  |t 0 
952 f f |a Massachusetts College of Pharmacy and Health Sciences  |b Online  |c Online  |d E-Collections  |t 0  |e NCBI  |h Other scheme 
856 4 0 |t 0  |u http://www.ncbi.nlm.nih.gov/books/NBK487233/  |y Full text